Canada markets close in 3 hours 42 minutes

Virpax Pharmaceuticals, Inc. (VRPX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.4900+0.2400 (+10.67%)
As of 11:28AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.76M
Enterprise Value -6.38M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.43
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.38

Trading Information

Stock Price History

Beta (5Y Monthly) 1.56
52-Week Change 3-72.49%
S&P500 52-Week Change 325.59%
52 Week High 311.7700
52 Week Low 32.1050
50-Day Moving Average 33.5789
200-Day Moving Average 35.4531

Share Statistics

Avg Vol (3 month) 325.73k
Avg Vol (10 day) 316.22k
Shares Outstanding 51.17M
Implied Shares Outstanding 61.17M
Float 8869.35k
% Held by Insiders 125.72%
% Held by Institutions 12.68%
Shares Short (Apr 15, 2024) 414.84k
Short Ratio (Apr 15, 2024) 40.88
Short % of Float (Apr 15, 2024) 41.71%
Short % of Shares Outstanding (Apr 15, 2024) 41.27%
Shares Short (prior month Mar 15, 2024) 423.86k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Mar 01, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-55.20%
Return on Equity (ttm)-164.09%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-15.19M
Diluted EPS (ttm)-12.9700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.14M
Total Cash Per Share (mrq)7.8
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.25
Book Value Per Share (mrq)1.65

Cash Flow Statement

Operating Cash Flow (ttm)-9.85M
Levered Free Cash Flow (ttm)-2.75M